Tissue microarrays for high-throughput molecular profiling of tumor specimens J Kononen, L Bubendorf, A Kallionimeni, M Bärlund, P Schraml, ... Nature medicine 4 (7), 844-847, 1998 | 5660 | 1998 |
The Banff 97 working classification of renal allograft pathology LC Racusen, K Solez, RB Colvin, SM Bonsib, MC Castro, T Cavallo, ... Kidney international 55 (2), 713-723, 1999 | 3825 | 1999 |
Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients L Bubendorf, A Schöpfer, U Wagner, G Sauter, H Moch, N Willi, ... Human pathology 31 (5), 578-583, 2000 | 2349 | 2000 |
Banff 07 classification of renal allograft pathology: updates and future directions K Solez, RB Colvin, LC Racusen, M Haas, B Sis, M Mengel, PF Halloran, ... American journal of transplantation 8 (4), 753-760, 2008 | 2332 | 2008 |
International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology KIM Solez, RA Axelsen, H Benediktsson, JF Burdick, AH Cohen, ... Kidney international 44 (2), 411-422, 1993 | 1784 | 1993 |
Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients HH Hirsch, W Knowles, M Dickenmann, J Passweg, T Klimkait, ... New England Journal of Medicine 347 (7), 488-496, 2002 | 1450 | 2002 |
Banff’05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (’CAN’) K Solez, RB Colvin, LC Racusen, B Sis, PF Halloran, PE Birk, ... American Journal of Transplantation 7 (3), 518-526, 2007 | 1417 | 2007 |
Antibody‐mediated rejection criteria–an addition to the Banff′ 97 classification of renal allograft rejection LC Racusen, RB Colvin, K Solez, MJ Mihatsch, PF Halloran, ... American Journal of Transplantation 3 (6), 708-714, 2003 | 1379 | 2003 |
Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations HH Hirsch, DC Brennan, CB Drachenberg, F Ginevri, J Gordon, ... Transplantation 79 (10), 1277-1286, 2005 | 1161 | 2005 |
Survey of gene amplifications during prostate cancer progression by high-throughput fluorescence in situ hybridization on tissue microarrays L Bubendorf, J Kononen, P Koivisto, P Schraml, H Moch, TC Gasser, ... Cancer research 59 (4), 803-806, 1999 | 903 | 1999 |
Tissue microarrays for rapid linking of molecular changes to clinical endpoints J Torhorst, C Bucher, J Kononen, P Haas, M Zuber, OR Köchli, F Mross, ... The American journal of pathology 159 (6), 2249-2256, 2001 | 773 | 2001 |
Tissue microarrays for gene amplification surveys in many different tumor types P Schraml, J Kononen, L Bubendorf, H Moch, H Bissig, A Nocito, ... Clinical Cancer Research 5 (8), 1966-1975, 1999 | 685 | 1999 |
Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases M de Peralta-Venturina, H Moch, M Amin, P Tamboli, S Hailemariam, ... The American journal of surgical pathology 25 (3), 275-284, 2001 | 678 | 2001 |
Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy V Nickeleit, T Klimkait, IF Binet, P Dalquen, V Del Zenero, G Thiel, ... New England Journal of Medicine 342 (18), 1309-1315, 2000 | 623 | 2000 |
High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma H Moch, P Schraml, L Bubendorf, M Mirlacher, J Kononen, T Gasser, ... The American journal of pathology 154 (4), 981-986, 1999 | 623 | 1999 |
Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors H Moch, T Gasser, MB Amin, J Torhorst, G Sauter, MJ Mihatsch Cancer 89 (3), 604-614, 2000 | 607 | 2000 |
Polyomavirus infection of renal allograft recipients: from latent infection to manifest disease V Nickeleit, HH Hirsch, IF BINET, F Gudat, O PRINCE, P Dalquen, G Thiel, ... Journal of the American Society of Nephrology 10 (5), 1080-1089, 1999 | 603 | 1999 |
Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss I Binet, V Nickeleit, HH Hirsch, O Prince, P Dalquen, F Gudat, MJ Mihatsch, ... Transplantation 67 (6), 918-922, 1999 | 557 | 1999 |
Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays L Bubendorf, M Kolmer, J Kononen, P Koivisto, S Mousses, Y Chen, ... Journal of the National Cancer Institute 91 (20), 1758-1764, 1999 | 488 | 1999 |
Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases G Feutren, MJ Mihatsch New England Journal of Medicine 326 (25), 1654-1660, 1992 | 475 | 1992 |